IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 27, 2026 from 10:55 am – 11:25 am (ET). A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will b.

Business Wire • May 14, 2026

Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency

Idexx Laboratories Inc (NASDAQ:IDXX) shares are up on Tuesday as the company recently announced strong first-quarter results, showcasing a 14% revenue growth.

Benzinga • May 5, 2026

Idexx Claws Down A Beat As Shares Bound Higher On A Guidance Hike

Idexx stock jumped early Tuesday on better-than-expected first-quarter sales and earnings. The firm raised its 2026 guidance.

Investors Business Daily • May 5, 2026

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 5, 2026

IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company reports revenues of $1,141 million for the first quarter of 2026, an increase of 14% as reported and 11% organic, driven by Companion Animal Group ("CAG") growth of 15% as reported and 12% organic. First quarter earnings per diluted share (“EPS”) were $3.47, an increase of 17% as reported and 15% on a c.

Business Wire • May 5, 2026

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates

Idexx Laboratories (IDXX) came out with quarterly earnings of $3.47 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $2.96 per share a year ago.

Zacks Investment Research • May 5, 2026

Idexx (IDXX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • May 5, 2026

IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up

IDXX rides strong on Q1 beats with rising margins; lifts 2026 outlook as diagnostics growth and innovation momentum fuel performance.

Zacks Investment Research • May 5, 2026

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Investment Research • May 4, 2026

GMED vs. IDXX: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • May 4, 2026